Medicenna Therapeutics | Ontario at the Biotech Showcase 2026

sfo_preprocess_html() call_user_func_array() (Line: 261) Drupal\Core\Theme\ThemeManager->render() (Line: 490) Drupal\Core\Render\Renderer->doRender() (Line: 248) Drupal\Core\Render\Renderer->render() (Line: 158) Drupal\Core\Render\MainContent\HtmlRenderer->{closure:Drupal\Core\Render\MainContent\HtmlRenderer::renderResponse():153}() (Line: 637) Drupal\Core\Render\Renderer->executeInRenderContext() (Line: 153) Drupal\Core\Render\MainContent\HtmlRenderer->renderResponse() (Line: 90) Drupal\Core\EventSubscriber\MainContentViewSubscriber->onViewRenderArray() call_user_func() (Line: 111) Drupal\Component\EventDispatcher\ContainerAwareEventDispatcher->dispatch() (Line: 186) Symfony\Component\HttpKernel\HttpKernel->handleRaw() (Line: 76) Symfony\Component\HttpKernel\HttpKernel->handle() (Line: 53) Drupal\Core\StackMiddleware\Session->handle() (Line: 48) Drupal\Core\StackMiddleware\KernelPreHandle->handle() (Line: 28) Drupal\Core\StackMiddleware\ContentLength->handle() (Line: 32) Drupal\big_pipe\StackMiddleware\ContentLength->handle() (Line: 201) Drupal\page_cache\StackMiddleware\PageCache->fetch() (Line: 138) Drupal\page_cache\StackMiddleware\PageCache->lookup() (Line: 87) Drupal\page_cache\StackMiddleware\PageCache->handle() (Line: 48) Drupal\Core\StackMiddleware\ReverseProxyMiddleware->handle() (Line: 51) Drupal\Core\StackMiddleware\NegotiationMiddleware->handle() (Line: 36) Drupal\Core\StackMiddleware\AjaxPageState->handle() (Line: 51) Drupal\Core\StackMiddleware\StackedHttpKernel->handle() (Line: 741) Drupal\Core\DrupalKernel->handle() (Line: 19)

Profile

Medicenna is a clinical-stage immunotherapy company pioneering best- and/or first-in-class Superkines - engineered cytokines designed to overcome the limitations of existing treatments in oncology and I&I diseases. Medicenna is backed by RA Capital and AIGH Capital. At Biotech Showcase, the company is focused on pharma/biotech partnering and investor meetings.

Lead programs:

Bizaxofusp: Ph3-ready program for glioblastoma with Orphan Drug Designation (FDA/EMA) and Fast Track (FDA)
MDNA11: emerging best-in-class IL-2 superagonist, being evaluated in solid tumors in an ongoing Ph 1/2 trial
MDNA113: first-in-class tumor-anchored PD-1/IL-2 bispecific, being evaluated in NHP with a FIH trial in H2 2026

medicenna.com

Contact

Daniel Scarr, Director, Corporate Development

Tel: +1 647-220-4509

Email: dscarr@medicenna.com

Event details

Name: Ontario at the Biotech Showcase 2026

Date: January 12 - 14, 2026

Event contact

Patricia Cosgrove

Area Director

USA: Life Sciences

+1 647-293-6306

patricia.cosgrove@ontario.ca

Participants

21 in total

20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for…
BioBox is a data integration and decision-intelligence platform for drug discovery. It helps biopharma bring…
Eurofins CDMO Alphora develops and…
Fibra turns everyday underwear into a real-time reproductive health platform — capturing critical biomarker data…
For over two decades, Toronto area-based GL CHEMTEC has been dedicated to delivering innovative…
HDAX Therapeutics, a biotechnology company pioneering a novel approach to target…
ImmunoBiochem is a pharma-partnered biotech developing novel bioconjugate therapeutics, such as…
Iseehear Inc. is a leading provider of comprehensive IT solutions for…
Kapoose Creek Bio is pioneering a new generation of therapeutics by fusing nature’s untapped chemistry with…
Lumerate is launching a new software brand called BioBackers - the intelligence platform for life science…
Medicenna is a clinical-stage immunotherapy company pioneering best- and/or first-in-class Superkines -…
Noa Therapeutics has developed a proprietary NRF2-…
Nucro-Technics is a GLP- and…
Paradox Immunotherapeutics is a biotech addressing the global burden of protein misfolding diseases—devastating…
Pattern Pharma’s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting…
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. PQ…
QurCan Therapeutics is advancing the next wave of genetic medicines for CNS…
Rhythm Biotherapeutics develops first-in-class, heart-derived exosome therapeutics to prevent atrial fibrillation…
Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number…
Tenomix’s mission is to develop novel technologies that target inefficiencies in the pathology workflow, optimize…
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide…